Brief: ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3
08/05/2026 11:50
May 08 (Reuters) - ANI Pharmaceuticals Q1 net income USD 29.5 million. Q1 adjusted EBITDA USD 63 million Q1 EPS USD 1.28 Q1 revenue USD 237.5 million vs. IBES estimate USD 207.6 million outlook FY adjusted EBITDA USD 285-300 million outlook FY revenue USD 1,080-1,140 million vs. IBES estimate USD 1,050 million outlook FY adjusted EPS USD 9.19-9.69 vs. IBES estimate USD 9.07
Recent news on ANI Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
ANI Pharmaceuticals Q1 revenue rises 21%, adjusted EPS beats estimates
Brief: ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma